Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations

Most gastrointestinal stromal tumors (GIST) have activating mutations in either KIT or PDGFRA. However, a small subset of GIST lacks either mutation. To investigate the molecular characteristics of GIST according to mutation type, protein expression profiles in 12 GIST (2 cases with PDGFRA mutations...

Full description

Saved in:
Bibliographic Details
Published inProteomics (Weinheim) Vol. 6; no. 4; pp. 1151 - 1157
Main Authors Kang, Hyun Ju, Koh, Kwi Hye, Yang, Eungi, You, Kwon Tae, Kim, Hee Jin, Paik, Young-Ki, Kim, Hoguen
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 01.02.2006
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Most gastrointestinal stromal tumors (GIST) have activating mutations in either KIT or PDGFRA. However, a small subset of GIST lacks either mutation. To investigate the molecular characteristics of GIST according to mutation type, protein expression profiles in 12 GIST (2 cases with PDGFRA mutations, 8 cases with KIT mutations and 2 cases lacking either mutation) were analyzed using 2‐DE and MALDI‐TOF‐MS. Comparative analysis of the respective spot patterns using 2‐DE showed that 15 proteins were differently expressed according to the mutation status. Expression levels of septin and heat shock protein (HSP) 27 were increased in GIST with KIT mutations and annexin V was overexpressed in GIST lacking either mutation. Among the 15 proteins, overexpression of 5 proteins [annexin V, high mobility group protein 1 (HMGB1), C13orf2, glutamate dehydrogenase 1 and fibrinogen beta chain] and decreased expression of RoXaN correlated with a higher tumor grade. These findings suggest that differential protein expression can be used as a diagnostic biomarker. Moreover, it may play a role in the development and progression of GIST according to activating mutation type, as these proteins have been shown to be involved in tumor metastasis, apoptosis and immune response.
Bibliography:istex:064C87AEDB8EEC67C1C38B9B1E1AC4CF73958367
ark:/67375/WNG-2C4WPK1N-8
ArticleID:PMIC200500372
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1615-9853
1615-9861
DOI:10.1002/pmic.200500372